BioPortUSA announced today the launch of a new strategic partnership with ECCA Nordic. The goal of this new relationship is to help facilitate cross border trade between life science companies based in Nordics and the United States. "We are thrilled that Minna Storm, CEO of ECCA Nordic has agreed to work with BioPortUSA. Her knowledge of the Swedish and Finnish markets makes her the perfect conduit to facilitate business opportunities for our two organizations"said Mark Lesselroth.
Jantelagen is the Swedish concept of achieving things collectively. It can be quite controversial, but translating this to embrace 21st century requirements is central to the ECCA Nordic way of doing business. In our new, connected world an updated version of Jantelagen offers a great platform for individual achievement to shine through.
ECCA Nordic is based in Stockholm but also has offices in Turku, Finland. Their focus in on helping Nordic based companies export their products to the world. Within the Healthcare sector they have developed a strong focus in the area of telemedicine.
"Having access to a firm like BioPortUSA will help simplify the market entry process for Nordic based companies who need to navigate the changing FDA regulatory environment, as well as legal, tax, insurance and commercialization requirements imposed by the US market." said Minna Storm
The collaboration between BioPortUSA and ECCA Nordic should provide a great platform for business growth and success between these two regions of the world.